ThinkEquity Assumes Optimer Pharma (OPTR) at Buy, Sets $25 Price Target
Tweet Send to a FriendGet Alerts OPTR Hot Sheet
Price: $14.48 -1.3%
Rating Summary:
5 Buy, 7 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Rating Summary:
5 Buy, 7 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 13
Trade OPTR Now!
ThinkEquity's James Molloy assumed coverage on Optimer Pharmaceuticals (NASDAQ: OPTR) with a Buy rating and $25 price target Monday morning.
The stock is up about 1.2 percent to $15.22 at last check.
For an analyst ratings summary and ratings history on Optimer Pharmaceuticals click here. For more ratings news on Optimer Pharmaceuticals click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The stock is up about 1.2 percent to $15.22 at last check.
For an analyst ratings summary and ratings history on Optimer Pharmaceuticals click here. For more ratings news on Optimer Pharmaceuticals click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Deutsche Bank Resumes CenterPoint Energy (CNP) at Hold
- Janney Capital Trims Numbers on Buckle (BKE), Margins Peaking
- Topeka Capital Starts CEVA Inc. (CEVA) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
ThinkEquity
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
